Exploring ways to enhance T cell activity against glioblastoma
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
This study is looking at ways to make treatments for glioblastoma, a tough type of brain cancer, work better by focusing on the immune system's T cells, and it aims to find new ways to boost these cells to help patients feel better.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10876404 on NIH RePORTER |
What this research studies
This research investigates the challenges of treating glioblastoma, a highly aggressive brain cancer, by focusing on the immune system's T cells. It aims to understand why current immunotherapies have not been effective and seeks to enhance T cell activation within the tumor environment. The research involves a collaborative team of experts who will explore combining different immunotherapy approaches to improve treatment outcomes for patients with glioblastoma. By studying the mechanisms of immune suppression in glioblastoma, the project hopes to develop more effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who may benefit from new immunotherapy strategies.
Not a fit: Patients with other types of brain tumors or those who are not eligible for immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with glioblastoma.
How similar studies have performed: While immunotherapy has shown success in other cancers, its application in glioblastoma is still being explored, making this research both relevant and necessary.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Chiocca, E. Antonio — Brigham and Women's Hospital
- Study coordinator: Chiocca, E. Antonio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.